Your browser doesn't support javascript.
loading
Endocrine Outcomes After Pituitary Surgery.
Buttan, Anshu; Mamelak, Adam N.
Affiliation
  • Buttan A; Department of Medicine, Division of Endocrinology, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Becker B-131, Los Angeles, CA 90048, USA.
  • Mamelak AN; Department of Neurosurgery, Cedars-Sinai Medical Center, 127 S San Vicente Boulevard, A6600, Los Angeles, CA 90048, USA. Electronic address: Adam.Mamelak@cshs.org.
Neurosurg Clin N Am ; 30(4): 491-498, 2019 Oct.
Article in En | MEDLINE | ID: mdl-31471056
Although removal of pituitary tumors yields excellent surgical outcomes, perturbations in the hypothalamic-pituitary axis are not uncommon. Careful assessment of postoperative hormone status with supplementation or further medical therapy is critical to successful outcomes. Although many centers routinely use perioperative steroids, they can be associated with worse outcomes in the absence of intact preoperative adrenal function or damage to the pituitary gland or stalk during surgery. Postoperative assessment of prolactin, cortisol, and growth hormone can be prognostic of surgical cure. Hormonal axes should be reevaluated routinely several weeks after surgery, because longitudinal monitoring is important for surgical and medical outcomes.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pituitary-Adrenal System / Pituitary Diseases / Hypothalamo-Hypophyseal System Limits: Humans Language: En Journal: Neurosurg Clin N Am Journal subject: NEUROCIRURGIA Year: 2019 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pituitary-Adrenal System / Pituitary Diseases / Hypothalamo-Hypophyseal System Limits: Humans Language: En Journal: Neurosurg Clin N Am Journal subject: NEUROCIRURGIA Year: 2019 Document type: Article Affiliation country: Country of publication: